Innovations in skeletal muscle regeneration: from physiology to bioengineering approaches for repair and restoration
Awad K., Aguirre J., Adegbite M., Sajeev Kumar A., Yacoub AS., Xia M.
Narrative Review, published in Front Physiol (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Narrative Review
- Journal
- Front Physiol (2026)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 42078212
- PMCID
- PMC13132708
- DOI
- 10.3389/fphys.2026.1789642
- Citations
- 1
Abstract (original English)
Skeletal muscle is a dynamic tissue essential for voluntary movement, metabolism, and thermoregulation. Yet, its intrinsic regenerative capacity is overwhelmed in volumetric muscle loss (VML), where damage exceeds the native repair threshold. Conventional treatments such as muscle flaps and grafts provide only partial structural and functional recovery, underscoring the need for regenerative strategies that more precisely recapitulate the molecular and cellular physiology of muscle healing. This review first outlines the physiology of injury and muscle regeneration, with emphasis on key molecular pathways that govern inflammation, fibrosis, and myogenesis in VML. Building on this biological framework, we then examine hydrogels as soft material platforms for skeletal muscle tissue engineering, including: (i) acellular hydrogels and nanoparticle-loaded hydrogels designed to modulate the biochemical and biophysical microenvironment; (ii) cell-loaded hydrogels that deliver myogenic or stem/progenitor cell populations; and (iii) drug-loaded hydrogels for localized, sustained release of growth factors, cytokines, nucleic acids, or small molecules. Finally, we discuss emerging directions, including nanoparticle-integrated systems, dynamically stiffening or softening hydrogels, and advanced biofabrication approaches, and consider how these cellularized and acellular drug-, cell-, or na
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.